Drug profile

The FDA adverse-event record for Arthritis Medication (Unknown)

30 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Arthritis Medication (Unknown). See the species affected, top reactions, and outcomes below.

30
adverse-event reports
3.3%
death-coded share
Dog
most-reported species
12
Emesis - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
30
Total Reports
1
Deaths Reported
3.3%
Death Rate

Active Ingredients

Arthritis Medication (Unknown)

Administration Routes

OralUnknownParenteral

Species Affected

Dog 28
Cat 2

Most Affected Breeds

Retriever - Labrador 5
Spaniel - Cocker American 2
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 2
Pit Bull 2
Retriever - Golden 2
Dog (unknown) 2
Dog (other) 1
Shiba Inu 1
Terrier - Yorkshire 1
Terrier - Cairn 1

Most Reported Reactions

Emesis 12
Lethargy (see also Central nervous system depression in 'Neurological') 4
Lack of efficacy - NOS 2
Panting 2
Vomiting 2
Shaking 1
Listless 1
Abnormal posture NOS 1
Loose stool 1
Lack of efficacy (endoparasite) - tapeworm 1
Disorientation 1
Sensory abnormality NOS 1

Outcome Breakdown

Recovered/Normal
20 (66.7%)
Outcome Unknown
7 (23.3%)
Died
1 (3.3%)
Recovered with Sequela
1 (3.3%)
Ongoing
1 (3.3%)

Arthritis Medication (Unknown) Adverse Event Insights

30 reports name Arthritis Medication (Unknown); 1 recorded a death outcome (3.3% of reported events, not a population-level mortality rate). Active ingredient: Arthritis Medication (Unknown). Administration routes: Oral, Unknown, Parenteral.

By species: Dog (28 reports), Cat (2 reports). By breed: Retriever - Labrador (5), Spaniel - Cocker American (2), Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) (2).

Leading clinical signs: Emesis (12), Lethargy (see also Central nervous system depression in 'Neurological') (4), Lack of efficacy - NOS (2), Panting (2). Outcome, 30 coded reports: Recovered/Normal leads at 66.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.